Sign in
4

Changes in Ownership

Travere Therapeutics, Inc. Filed Acc 0001209191-20-007720

Director sold 2,500 shares at $16.62 ($41,550)

From the SEC's structured data for this filing

Trades in this filing

ASELAGE STEVE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-02-05 Sale : show line 1 in the form −2,500 $16.62 $41,550 248,466 D
Open-market sales · 2,500 sh · avg $16.62 · $41,550
Loading xslF345X03/doc4.xml…